Crotylbarbital
Appearance
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Zakblade2000 (talk | contribs) at 14:42, 11 October 2018. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 14:42, 11 October 2018 by Zakblade2000 (talk | contribs)
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.016.162 |
Chemical and physical data | |
Formula | C10H14N2O3 |
Molar mass | 210.23 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Crotylbarbital (Mepertan, Kalipnon, Barotal), also known as crotarbital, is a barbiturate derivative developed by Eli Lilly in the 1930s[1]m It has sedative and hypnotic effects,[2] and was used for the treatment of insomnia until it was replaced by newer alternative drugs with less side effects and lower risk of overdose.
See also
References
Alcohols | |
---|---|
Barbiturates |
|
Benzodiazepines |
|
Carbamates | |
Flavonoids |
|
Imidazoles | |
Kava constituents | |
Monoureides | |
Neuroactive steroids |
|
Nonbenzodiazepines | |
Phenols | |
Piperidinediones | |
Pyrazolopyridines | |
Quinazolinones | |
Volatiles/gases |
|
Others/unsorted |
|
Hidden categories: